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Background: Peri-implantitis is a chronic inflammation, resulting in loss of supporting bone around implants.
Chronic periodontitis is a risk indicator for implant failure. Both diseases have a common etiology regarding
inflammatory destructive response. BRINP3 gene is associated with aggressive periodontitis. However, is still unclear
if chronic periodontitis and peri-implantitis have the same genetic background.
The aim of this work was to investigate the association between BRINP3 genetic variation (rs1342913 and
rs1935881) and expression and susceptibility to both diseases.
Methods: Periodontal and peri-implant examinations were performed in 215 subjects, divided into: healthy (without
chronic periodontitis and peri-implantitis, n = 93); diseased (with chronic periodontitis and peri-implantitis, n = 52);
chronic periodontitis only (n = 36), and peri-implantitis only (n = 34). A replication sample of 92 subjects who lost
implants and 185 subjects successfully treated with implants were tested. DNA was extracted from buccal cells. Two
genetic markers of BRINP3 (rs1342913 and rs1935881) were genotyped using TaqMan chemistry. Chi-square (p <
0.05) compared genotype and allele frequency between groups. A subset of subjects (n = 31) had gingival biopsies
harvested. The BRINP3 mRNA levels were studied by CT method (2
ΔΔCT). Mann–Whitney test correlated the levels of
BRINP3 in each group (p < 0.05).
Results: Statistically significant association between BRINP3 rs1342913 and peri-implantitis was found in both
studied groups (p = 0.04). The levels of BRINP3 mRNA were significantly higher in diseased subjects compared to
healthy individuals (p = 0.01).
Conclusion: This study provides evidence that the BRINP3 polymorphic variant rs1342913 and low level of BRINP3
expression are associated with peri-implantitis, independently from the presence of chronic periodontitis.
Keywords: Chronic periodontitis, Peri-implantitis, Genetic polymorphism, Gene expressionBackground
Peri-implantitis represents a collective term for chronic
inflammatory processes affecting the tissues surrounding
osseointegrated dental implants and resulting in loss of
supporting bone [1]. A series of risk indicators for im-
plant survival, such as lack of oral hygiene, diabetes,* Correspondence: arv11@pitt.edu
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unless otherwise stated.smoking, and history of chronic periodontitis [2], has been
related to the development of peri-implantitis [3]. Individ-
uals with a history of periodontitis and loss of supporting
bone may experience more implant loss and complica-
tions around implants than non-periodontitis patients [4].
Periodontal pathogens transmitted from residual dentition
to the implant sites can be detected around an implant
one month after reopening surgery [5].
Studies concerning the etiopathogenesis of peri-
implantitis are based on the development of the peri-
odontal disease. In periodontitis, the local inflammatory. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Casado et al. BMC Oral Health  (2015) 15:33 Page 2 of 10reaction to bacterial infection activates the innate im-
mune system, resulting in the release of an array of me-
diators that propagate the inflammation throughout the
gingival tissues [6,7]. Previous studies indicated that
chronic periodontitis [8,9], as well as peri-implantitis
[10-15], may have a genetic background. However, there
is no definitely identified genetic polymorphism that ex-
plains biological complications in dental implants [16].
In addition, studies considering the association between
genetic predisposition and implant failure have a weak
point: the lack of data reporting the periodontal status of
the patients.
Carvalho et al. [17] have shown that aggressive peri-
odontitis is associated with markers in BRINP3 (bone
morphogenetic protein/ retinoic acid inducible neural-
specific 3, previously referred as FAM5C). BRINP3 is re-
lated to several cellular functions, such as proliferation,
migration, and programmed cell death, and is related to
several diseases, including invasion of pituitary tumors,
atherosclerosis [18], and myocardial infarction [19]. The
BRINP3 single nucleotide polymorphism rs1935881 was
associated with norepinephrine change during exercise
[20]; the same BRINP3 variant we found to be associated
to aggressive periodontitis in 389 subjects evaluated from
55 pedigrees [17]. Motivated by the evidence that BRINP3
contributes to aggressive periodontitis we decided to in-
vestigate the role of BRINP3 in peri-implantitis. Our
research group raised two questions: (i) Do BRINP3 poly-
morphisms predispose to peri-implantitis in patients with
chronic periodontitis? (ii) Does the genetic background as-
sociated to BRINP3 gene predispose to chronic periodon-
titis and peri-implantitis by the same way? In the present
work, we looked for evidence that BRINP3 may contribute
to peri-implantitis and chronic periodontitis by testing for





Two hundred and fifteen individuals, presenting 754
osseointegrated endosseous implants, were randomly re-
cruited for the study from the patients’ pool at the Den-
tal Clinics of the Faculty of Dentistry, Fluminense
Federal University, Niterói, and Veiga de Almeida Uni-
versity, Rio de Janeiro, Rio de Janeiro, Brazil, during one
year. Clinical procedures were conducted according to
recommendations from both Universities’ Research Eth-
ics Boards (Registration number 238/10 and 0070621
2.9.0000.5243 12/09, respectively). Informed consent was
obtained from all participants. The baseline clinical pa-
rameters for the subject population are shown in Table 1.
Subjects answered a personal, medical, and dental his-
tory anamnesis (Additional file 1), as well as had theirsmoking habit and alcohol consumption recorded. The
exclusion criterion was implant failure before osseointe-
gration period. The inclusion criteria were: to have at
least one osseointegrated endosseous implant, immedi-
ate postoperative radiography showing the vertical bone
level around implant in order to compare bone level
after osseointegration period, periapical radiography
showing periodontal status before implant placement,
and to be under maintenance care annually for both a
clinical and radiographic examination. All implants were
placed in a submerged modality (two-stage concept) in
sites previously showing favorable bone quality and
quantity. Either single crowns or short span fixed partial
dentures supported implants.
Diagnosis of peri-implantitis
All peri-implant regions were clinically and radiograph-
ically evaluated. Clinical examination of the peri-implant
sites consisted of visual inspection and palpation, ana-
lysis of mucosa inflammation, edema, probing pocket
depth, bleeding on probing and spontaneous bleeding in
four aspects (mesial, buccal, distal and lingual/palatine),
plaque index, peri-implant phenotype [21], and implant
mobility. One single examiner (P.L.C.) performed all
evaluations according to the same guidelines. No calibra-
tion protocol was implemented. Conventional periapical
radiography, using the paralleling technique, was used to
assess the presence of vertical bone loss around the im-
plants by measuring the height of peri-implant bone
compared to initial radiography immediate after implant
placement. According to the clinical and radiographic
characteristics of the peri-implant sites, subjects were
characterized as having healthy sites-no clinical signs of
inflammation in the peri-implant mucosa and no signs
of bone loss–or peri-implantitis–radiographic signs of
pathologic bone loss in at least one region (Table 1).
Physiological bone loss was characterized considering
the normal bone loss of 1 mm at the first year after im-
plant placement and 0.2 mm for subsequent years [22].
According to the implant osseointegration period, the
total amount of bone loss was calculated based on the
difference between immediate postoperative radiography
and diagnosis radiography (at the moment of peri-
implant examination). If the total of bone loss was su-
perior to 1 mm and 0.2 mm for year, the patient was
considered to have peri-implantitis.
Diagnosis of chronic periodontitis
Subjects were characterized as healthy (without history
of chronic periodontitis) or with chronic periodontitis
(with history of chronic periodontitis).
The diagnosis of chronic periodontitis was established
on the basis of radiographic parameters, including peria-
pical radiographic analysis showing horizontal bone







only (n = 36)
Peri-
implantitis
only (n = 34)
p-value
n (%) n (%) n (%) n (%) Healthy Healthy Healthy Diseased Diseased Chronic
periodontitis
only












Whites 83 (89.2) 48 (92.3) 29 (80.5) 29 (85.3) 0.54 0.19 0.54 0.29 0.10 0.59
Non-Whites 10 (10.8) 4 (7.7) 7 (19.5) 5 (14.7)
Age (years) 51.2 ± 13.3 59.2 ± 10.3 58.5 ± 11.4 55.1 ± 11.8 0.001 0.01 0.68 0.71 1.0 1.0
Sex
Female 61 (65.6) 38 (73.0) 25 (69.5) 24 (70.6) 0.35 0.67 0.59 0.80 0.71 0.91
Male 32 (34.4) 14 (27.0) 11 (30.5) 10 (29.4)
Smoking
Non-smoking 86 (92.5) 45 (86.5) 30 (83.3) 33 (97.0) 0.24 0.12 0.34 0.10 0.67 0.05
Smoking 7 (7.5) 7 (13.5) 6 (16.7) 1 (3.0)
Alcohol
Consumption
No 49 (52.7) 29 (55.7) 21 (58.3) 24 (70.6) 0.72 0.56 0.07 0.16 0.81 0.28





0.12 ± 0.33 0.62 ± 0.48 0.19 ± 0.4 0.55 ± 0.5 0.0001 1.0 0.0001 1.0 0.07 0.002
Spontaneous
bleeding
0 0.11 ± 0.32 0 0.14 ± 0.35 0.0001 1.0 0.004 1.0 0.07 0.02
Probing pocket
depth (mm)
1.55 ± 0.74 2.4 ± 1.38 1.58 ± 0.66 2.45 ± 1.03 0.04 1.0 0.08 1.0 0.04 0.05
Plaque index 0.03 ± 0.18 0.31 ± 0.46 0.22 ± 0.42 0.17 ± 0.38 0.0001 0.04 0.2 0.4 1.0 1.0
Peri-implant
phenotype
Thin 35 (37.6) 29 (55.7) 18 (50) 13 0.03 0.2 0.95 0.11 0.59 0.32
Thick 58 (62.4) 23 (44.2) 18 (50) 21















Table 1 Baseline characteristics of the discovery sample (Continued)
External hexagon 44 (47.3) 29 (55.8) 20 (55.5) 21 (61.8) 0.9 1.0 1.0 1.0 1.0 1.0
Internal hexagon 8 (8.6) 6 (11.5) 2 (5.5) 2 (5.9)
Morse Cone 35 (37.7) 17 (32.7) 13 (36.2) 10 (29.4)
Others 6 (6.4) 1 (2.8) 1 (2.9)
Implant region
Superior 122 (54.5) 126 (50.2) 47 (30.0) 64 (53.3) 0.3 0.0001 0.8 0.5 0.0001 0.0001
Inferior 102 (45.5) 127 (49.8) 110 (70.0) 56 (46.7)
Osseointegration
period (months)
35.53 ± 34.01 37.8 ± 47.1 29.97 ± 21.92 31.7 ± 23.7 1.0 1.0 1.0 1.0 1.0 1.0
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clinical examination and past dental history, in order to
differentiate chronic from aggressive periodontitis.
Subjects with chronic periodontitis had to present the
following periodontal criteria: (i) diagnosis and classifica-
tion of generalized chronic periodontitis based on the
1999 Consensus Classification of Periodontal Diseases
[23]; (ii) presence of periodontal pockets with clinical at-
tachment loss of ≥5 mm, bleeding on probing, and
radiographic bone loss; (iii) age over 35 years; (iv) at
least eight teeth with a probing pocket depth of ≥5 mm
and bleeding after pocket probing and with at least two
of the eight qualifying teeth presenting probing pocket
depth ≥ 7 mm by clinical examination or as recorded in
the patients chart. All subjects diagnosed with chronic
periodontitis had been treated for chronic periodontitis
and were under regular maintenance.
Based on peri-implant and periodontal status, subjects
were divided into four groups: healthy (without chronic
periodontitis history and peri-implantitis, n = 93); diseased
(with chronic periodontitis history and peri-implantitis,
n = 52); chronic periodontitis only (with chronic periodon-
titis history without peri-implantitis, n = 36), and peri-
implantitis only (with peri-implantitis without chronic
periodontitis, n = 34) in order to analyze each disease sep-
arately within the discovery sample.
DNA collection and purification
Genomic DNA was obtained from saliva samples of 215
subjects following a previously described protocol [24].
The amount and purity of the DNA was determined by
spectrophotometer (Nanodrop® 1000, Thermo Scientific,
Wilmington, USA). Only DNA samples presenting A2
60nm/A280nm ratio greater than 1.7 were used.
Replication sample
Subject selection
For replication purposes, we tested a second cohort. A
total of 3.578 patient records from the Latin-American
Dental Research Institute (ILAPEO) of Curitiba city,
Paraná, Brazil, were analyzed in this study. All patients
were implant treated (Neodent Implantes Osseointegrá-
veis, Curitiba/PR, Brazil) between 1996 and 2006, and
out of 3.578 subjects treated, 126 patients (3.5%) pre-
sented implant loss. Early failure associated to peri-
implantitis represented the majority of cases (88.2% or
187/212). From these 126 individuals, 92 were evaluated
(34 were not evaluated because of death or address
change) and diagnosed as peri-implantitis based on pre-
viously described criteria. The comparison group was
composed of 185 patients treated with osseointegrated
implants in function for at least six months and without
any loss (healthy peri-implant tissue group). The groups
were matched by sex, age, and smoking habits (Table 2).Thus, the sample was composed of 277 unrelated subjects
of both sexes with a mean age 53.63 ± 11.14 years (range
27.1–86.9 years). All participants were advised previously
about the nature of the study and signed a consent form
within a protocol approved by an Institutional Review
Board (Ethical Committee in Research at Pontif ícia Uni-
versidade Católica do Paraná, protocol 323/06). Subjects
answered a personal, medical, and dental history anam-
nesis, as well as had their socioeconomic profile assessed
according to Brazilian Economical Classification Criteria–
2003; general medical condition, current medication, tooth
brushing, use of dental floss and mouthwash, dental ap-
pointment frequency, and clinical data-such as number of
teeth and placed dental implants–was recorded (Additional
file 2). Cases were also subdivided into subjects with single
implant loss (n = 69) and cases presenting multiple implant
loss (which means more than one implant lost in the same
or different sites; n = 23).
Periodontal status
The following parameters were recorded in partially
edentulous patients (controls = 151, cases = 85): gingival
index [25], plaque index [26], calculus index [27], prob-
ing pocket depth, clinical attachment loss, and mobility
(absent or present). Periodontal measurements were re-
corded from four sites on each tooth using a millimeter
conventional periodontal probe (PCP11; Hu-Friedy™,
Chicago, IL, USA) and all these clinical data were col-
lected by one examiner (F.A.). The periodontal status of
all subjects is shown in Table 2.
DNA collection and purification
From all subjects, epithelial buccal cells were collected
according to a previously described protocol [28]. DNA
was extracted from epithelial buccal cells with ammo-
nium acetate 10 M and EDTA 1 mM [29].
Single nucleotide polymorphism selection and
genotyping
We selected two variants in BRINP3 (rs1342913 and
rs1935881) that have been previously associated with ag-
gressive periodontitis [17]. These polymorphisms are lo-
cated in chromosome 1 at base pair 190121025 in the
BRINP3 intron and at base pair 190066386 in the untrans-
lated region of the gene, respectively. Real time polymerase
chain reactions with TaqMan chemistry (Applied Biosys-
tems, Foster City, CA, USA) held in total 1.5 μL/reaction
were used for genotyping the selected markers in a PTC-
225 tetrad termocycler (Peltier Thermal Cycler, Bio-Rad
Life Science, Corston, UK).
Evaluation of the BRINP3 expression
Gingival biopsies were harvested from 31 patients from
the total dataset of the discovery sample after the









Whites 176 (95.1%) 91 (98.9%) 0.17
Non-Whites 9 (4.9%) 1 (1.1%)
Mean Age in Years 53.13 ± 11.46 54.63 ± 10.44 0.29
Sex
Females 122 (66%) 56 (60.9%) 0.43
Males 63 (34%) 36 (39.1%)
Smoking Status
Non-Smoking 142 (76.8%) 74 (80.4%) 0.54
Smoking 43 (23.2%) 18 (19.6%)
Implant Loss
Single - 69 (75%)
Multiple - 23 (25%)
Periodontal Status
(partially edentulous
subjects; n = 236)
(n = 151) (n = 85)
Gingival index 0.64 ± 0.37 0.65 ± 0.53 0.89
Plaque index 0.12 ± 0.23 0.23 ± 0.41 0.96
Calculus index 0.07 ± 0.12 0.13 ± 0.24 0.28
Probing Pocket
Depth (mm)
2.72 ± 0.46 2.54 ± 0.47 0.005
Clinical Attachment
Loss (mm)
3.62 ± 0.85 3.66 ± 1.07 0.76
Mobility 19 15 0.33
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procedure. Samples were collected from thirteen sub-
jects from the healthy group, nine from the diseased
group, six from the chronic periodontitis only group,
and three from the peri-implantitis group.
Total RNA from gingival samples was isolated using
Trizol® Reagent (Invitrogen™ by Life Technologies, NY,
USA) method according to the manufacturer’s protocol.
DNase treatment to digest genomic DNA that could lead
to false positive gene expression results was done using
DNA-free DNase® (Ambion by Invitrogen™ by Life Tech-
nologies, NY, USA). RNA integrity was confirmed on a
1.2% agarose denaturing gel electrophoresis stained with
SYBR Nucleic Acid Gel Stain® (Invitrogen™ by Life Tech-
nologies, NY, USA). RNA quantity was assessed with the
spectrophotometer (Nanodrop® 1000, Thermo Scientific,
Wilmington, USA). The reverse transcriptase for the
synthesis of complementary DNA (cDNA) was made in
duplicates, from 1 μg of RNA using the system ImProm-
II Reverse Transcription System™ (Promega Corporation,
Wisconsin, USA), according to the manufacturer’s
protocol. Reactions without transcriptase reverse enzyme
were performed. The qPCR reactions were run in theMxPro-Mx3005p software (Stratagene/Agilent Technolo-
gies, Wilmington, DE, USA) using the detection system
Fast Sybr Green Master Mix (Applied Biosystems, Foster
City, CA, USA) with 1.5 μl of cDNA in each reaction.
qPCR was performed with an activation step at 95°C for
10 minutes, followed by 40 cycles of denaturation and an-
nealing/extension (95°C for 15 seconds and 60°C for 1 -
minute). Primers used were for exons 7 and 8 forward
5’ATATACAGGGAGTTTGGCCGC3’ and reverse 5’GAA
TTCAGGGGCAAGAGGCA3’ and for exons 2 and 3
forward 5’GCCTGCCAAGACAAAGAACC3’ and 5’
CACGAGTGCGTGTCTTCTGA3’. A melt curve was
performed for specific amplification analysis. The
Livak Method (2-ΔΔCT) was used to determine the rela-
tive quantification of BRINP3 expression. Values were
normalized with respect to constitutive expression of β-
actin (sense 5’-TAC AAT GAG CTG CGT GTG G–3’/
antisense 5’-AGA GGC GTA CAG GGA TAG CA–3’).
Data are presented as fold change relative to a calibrator
(RNA pool from all samples). All reactions were per-
formed in duplicate.Statistical analyses
To access the significance of nominal variables between
groups, the chi-square (χ2) test was performed. Continu-
ous variables were expressed as mean and standard devi-
ation. Then, ANOVA or Mann–Whitney tests were used
to compare means between groups when the variable was
in a normal or non-normal distribution (gene expression).
Differences in the prevalence of genotypes and alleles be-
tween groups were analyzed using the Pearson chi-square
(χ2) test after fitting testing for Hardy-Weinberg equilib-
rium. Values of p < 0.05 were considered statistically sig-
nificant. Multinominal logistic regression analyses were
performed to permit the exploration of many covariates
simultaneously. Statistical analyses were performed using
STATA 11.1 (StataCorp, Texas USA).Results
Association studies in the discovery sample
Results of the association studies between BRINP3
markers and peri-implantitis in the discovery sample are
summarized in Table 3. Genotype distributions were
within Hardy-Weinberg equilibrium (data not shown).
The TT genotype of BRINP3 rs1935881 was associated
with peri-implantitis only (p = 0.04). In addition, the fre-
quency of polymorphic genotypes (CT + TT) and T allele
was significantly higher in peri-implantitis only cases com-
pared to chronic periodontits only cases (p = 0.009/0.01)
and to cases with both peri-implantitis and chronic peri-
odontitis (p = 0.04/0.01). G allele for BRINP3 rs1342913
also showed high prevalence in peri-implantitis group
compared to chronic periodontitis only (p = 0.04).










n (%) n (%) n (%) n (%) Healthy Healthy Healthy Diseased Diseased Chronic
periodontitis only














AA 31 (33.7) 11 (22) 12 (34.3) 7 (21.2) 0.29 0.25 0.34 0.6 0.2 0.08
AG 39 (42.4) 27 (54) 19 (54.3) 15 (45.4)
GG 22 (23.9) 12 (24) 4 (11.4) 11 (33.4)
AG + GG 61 (66.3) 39 (78) 23 (65.7) 26 (78.8) 0.14 0.94 0.1 0.93 0.2 0.2
A 101
(54.9)
49 (49) 43 (61.4) 29 (44) 0.34 0.34 0.12 0.5 0.1 0.04
G 83 (45.1) 51 (51) 27 (38.6) 37 (56)
rs1935881
CC 7 (7.6) 6 (12) 7 (20) 0 0.65 0.1 0.12 0.05 0.4 0.03
CT 40 (43.5) 22 (44) 11 (31.4) 10 (33.3)
TT 45 (48.9) 22 (44) 17 (48.6) 20 (66.7)
CT + TT 85 (92.4) 44 (88) 28 (80) 30 (100) 0.38 0.04 0.1 0.04 0.3 0.009
C 54 (29.3) 34 (34) 25 (35.7) 10 (16.6) 0.41 0.32 0.05 0.01 0.8 0.01
T 130
(70.6)
66 (66) 45 (64.3) 50 (83.4)
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logistic regression of individual parameters in diseased
groups of the discovery sample was performed. This
yielded adjusted odds ratios (OR) for individual parame-
ters, including age, sex, ethnic group, smoking, and alco-
hol consumption (Additional file 3). When analyses were
adjusted for other risk factors, no association with BRINP3
was detected. Age showed a trend for association with in-
dividuals with both diseases (p = 0.00001; OR = 3.6, 95%
C.I. 0.9-10.7) and chronic periodontitis alone (p = 0.002;
OR = 3.0; 95% C.I. 0.8-10.52), suggesting that the differ-
ence in the distribution of BRINP3 alleles between healthy
and individuals affected by peri-implantitis is confounded
by the difference in the age of both groups (healthy indi-
viduals were on average 8 years younger than the affected
individuals; Table 1). Also, smoking represented a signifi-
cant risk factor for individuals with chronic periodontitis
only (p = 0.03).
Association studies in the replication sample
Taking into consideration the association of BRINP3
rs1935881 and rs1342913 polymorphisms and the oc-
currence of peri-implantitis, we analyzed the associ-
ation between BRINP3 markers and peri-implantitis in
the replication sample based on groups divided accord-
ing to peri-implant status (Additional file 4). Genotype
distributions were within Hardy-Weinberg equilibrium
(data not shown). There is an excess of heterozygotes
for the BRINP3 rs1342913 in cases with peri-implantitis
(p = 0.04). These results appear to be driven by cases
with single dental implant losses (p = 0.027).Gene expression results
To support the potential association of BRINP3 genes
with the pathogenesis of chronic periodontitis and peri-
implantitis, we investigated their expression in diseased
and healthy peri-implant tissues (Figure 1). BRINP3
(exon 7–8 primers) expression was significantly higherFigure 1 Expression levels of BRINP3 gene (log 10 scale). Messenger R
Values represent the relative expression values as determined by 2-ΔΔCT. Disin cases with diseased tissues (chronic periodontitis +
peri-implantitis) compared to healthy tissues (p = 0.01).
We observed a tendency to higher expression in tissues
from individuals with both peri-implantitis and chronic
periodontitis compared to tissues from individuals with
peri-implantitis only (p = 0.05). Although results for
BRINP3 exon 2–3 primers expression were not statisti-
cally significant, a similar trend of higher expression in
diseased tissues compared to healthy tissues (p = 0.06)
and in individuals with both peri-implant disease and
chronic periodontitis compared to tissues from individ-
uals with peri-implantitis only (p = 0.07), could be seen.
In both BRINP3 experiments, lower expression was ob-
served in peri-implantitis samples.
Discussion
Evidence that implant failures tend to increase in subsets
of individuals [30] may indicate that specific characteris-
tics of the host, such as genetic factors, can jeopardize the
osseointegration process [31]. The previous history of
periodontitis has shown to influence the success rate in
implant dentistry [2,32] and patients without history of
chronic periodontitis present a higher average of implant
survival in comparison with individuals with history of
periodontitis.4 Our work supports the initial hypothesis
that peri-implantitis and BRINP3 are associated and these
results appear to be independent from the presence of
chronic periodontitis, which suggests that if chronic peri-
odontitis contributes to implant failure, it acts through a
pathway not involving BRINP3.
The percentage of Black subjects in our sample is
smaller that one would expect in the population how-
ever this can be explained by the fact that Blacks in
Brazil over-represent lower socioeconomic groups and
hence are less likely to receive more complex dental
treatments such as dental implants. Since the original
observation of an association between BRINP3 and ag-
gressive periodontitis was made in a population data set
enriched by Black families, it is possible that theNA expression levels for BRINP3 exons 7–8 and 2–3 in gingival samples.
eased = chronic periodontitis + peri-implantitis.
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failure is stronger in individuals of African heritage.
In order to elucidate the relation of BRINP3 as genetic
contributor to both diseases, we evaluated the distribution
of genotypes of markers which frequencies and linkage
disequilibrium relationships were previously described in
the International HapMap Project [33]. BRINP3 is local-
ized in mitochondria and its over-expression leads to in-
creased proliferation and migration of cells [18]. Through
complex signaling cascades, mitochondria have the ability
to activate multiple pathways that modulate both cell pro-
liferation and, inversely, promote cell arrest and pro-
grammed cell death [34] – all phenomena relevant in the
pathogenesis of periodontitis and peri-implantitis. Our
genetic analysis suggests BRINP3 polymorphisms are re-
lated to the development of peri-implantitis even without
chronic periodontitis as a risk factor for peri-implantitis
development. Difference in peri-implantitis gene expres-
sion was also observed. A tendency to lower BRINP3 ex-
pression in peri-implantitis tissues was clearly identified.
In contrast, patients with both diseases showed significant
higher BRINP3 gene expression, which can reflects the po-
tential exacerbated reaction that BRINP3 can induct in the
chronic periodontitis process. It can suggest that the gen-
etic characteristic that conducts resorption reactions
around teeth in chronic periodontitis patients probably re-
mains in peri-implant tissue after implant placement, trig-
gering implant failure. However, patients without chronic
periodontitis history also can trigger a peri-implant bone
loss despite the minimum BRINP3 mRNA expression.
Therefore, these findings still need to be explored.
In spite the fact that chronic periodontitis is a risk indi-
cator for peri-implantitis, previous studies including gen-
etic analysis of peri-implantitis did not differentiate
patients with or without chronic periodontitis in order to
establish the genetic background of peri-implantitis by it-
self. Possibly, specific factors are acting by different path-
ways to originate peri-implantitis in patients without
history of chronic periodontitis. Indeed, lower levels of
BRINP3 observed in mucosae from peri-implantitis only
cases can reflect that peri-implantitis without interaction
with chronic periodontitis history has different behaviors.
Based on our results, we can suggest that BRINP3 geno-
types and expression are correlated to peri-implantitis,
even without chronic periodontitis history. This associ-
ation may be particularly relevant in cases of single dental
implant losses. However, future studies are necessary, con-
sidering the BRINP3 function in vitro and in vivo and its
association with bone loss response in separate cases of
chronic periodontitis and peri-implantitis.
Conclusions
This study provides evidence that BRINP3 polymorphic
variants and low level of BRINP3 expression are associatedwith peri-implantitis, independently from the presence of
chronic periodontitis.
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